Sign inJoin waitlistJoin the waitlist

Marisa Tungsiripat

Physician · Cleveland Clinic

Credentials: · · ·

History

Cleveland Clinic
Present

Washington University School of Medicine
2003–2004
Infectious Disease
Washington University/B-JH/SLCH Consortium
1998–2000
Yale-New Haven Hospital
1995–1998
University of Missouri–Kansas City School of Medicine
1991–1995
University of Missouri-Kansas City School of Medicine
1987–1991

Research

Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy
Clinical Infectious Diseases · 2009 · 205 citations
Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy
Review · Clinical Infectious Diseases · 2006 · 119 citations
A pilot study to determine the impact on dyslipidemia of adding tenofovir to stable background antiretroviral therapy: ACTG 5206
AIDS · 2010 · First of 10 authors · Corresponding · 114 citations

Grace McComsey
8 papers
Allison Eckard
4 papers · 4 as a fellow
Dalia El Bejjani
4 papers
Judith Aberg
4 papers
NR
Nesrine Rizk
4 papers
Corrilynn Hileman
2 papers
Henning Drechsler
2 papers
Marshall Glesby
2 papers
Vikram Dogra
2 papers
AT
Alan Taege
1 paper
BB
Bethany Burns
1 paper · 1 as a fellow
Carl Fichtenbaum
1 paper

Grants

Metabolic Complications of HIV and Responses to Pioglitazone
National Institute of Allergy and Infectious Diseases · K23
Contact PI · $645.3K · Cleveland Clinic Lerner Com-Cwru
2007–2013

Clinical trials

Switching From Efavirenz to Atazanavir/ Ritonavir in HIV-infected Subjects With Good Virologic Suppression
Principal investigator · Terminated · Phase 4
The Cleveland Clinic
2010–2011
Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug Therapy
Study chair · Completed
National Institute of Allergy and Infectious Diseases (NIAID)
2005–2007